Alnylam Pharmaceuticals – Safety and Risk Management Postdoctoral Research Fellow at Northeastern University in Boston, MA

Job description

About the Opportunity About the Opportunity Northeastern University Pharmaceutical Industry Fellowships Program is a two-year experiential program designed to advance lifelong learning and the education and training of Pharm.D. graduates. A key element of the program’s success is preparing Fellows to meet evolving workforce needs across various sectors of the pharmaceutical industry. Fellows have the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year Safety and Risk Management fellowship, based in Cambridge, MA. About Alnylam We are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what’s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We're proud to be a globally recognized top employer, where an authentic, inclusive culture and breakthrough thinking fuel one another. At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. Qualified applicants will receive consideration for employment without regard to their sex, gender or gender identity, sexual orientation, race, color, ethnicity, national origin, ancestry, citizenship, religion, creed, physical or mental disability, pregnancy status or related conditions, genetic information, veteran or military status, marital or familial status, political affiliation, age, or any other factor protected by federal, state, or local law. Responsibilities Safety and Risk Management (SRM) oversees all activities related to the detection, assessment, understanding, and prevention of adverse effects or other medicine-related safety concerns to ensure safe use of medicines and to safeguard health of patients. The fellow can expect to gain a thorough understanding of pharmacovigilance activities and actively participate in the development and maintenance of the drug safety profiles for our revolutionary RNAi platform. Key Job Duties: Provide scientific and strategic assistance to Safety Product Leads to support Alnylam products Participate in the collection, interpretation, and presentation of safety data in internal forums Support signal detection and management activities with Lead Safety Physicians and PV Scientists Engage in safety data review, analysis, and reporting of safety data to internal and external stakeholders by planning, managing, and authoring safety aggregate reports (e.g. PBRERs, DSURs) Participate in the development and management of Risk Management Plans Qualifications • Doctor of Pharmacy degree from an ACPE-accredited institution • Eligible for pharmacist licensure in the State of Massachusetts • Excellent oral and written communication skills • Strong time management and leadership abilities • Ability to work independently and take initiative on a variety of projects at both the industry site and Northeastern Additional Information Applicants should submit the following application materials by the priority deadline of October 31, 2026: 1. Curriculum vitae (CV), uploaded 2. Unofficial PharmD transcripts, uploaded 3. Cover letter, uploaded Letters of Recommendation Three formal Letters of Recommendation (LORs) must be submitted directly by the letter writers no later than November 23, 2026 . Each letter writer must include: · The candidate's full name · The fellowship program(s) to which the candidate is applying (e.g., Smith, John – Alnylam, GSK ) Please ask your letter writers to complete and submit t